Skip to Content
 

News: December, 2019

Study finds breast cancer recurrence score has different implications for men

Sunday, December 22nd, 2019

A study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence. However, a new study finds this conclusion may not directly apply to male patients with the same type of breast cancer

Cell fate signaling

Saturday, December 21st, 2019

A newly identified protein interaction that affects cell cycle regulation may be an attractive target for cancer therapy.

ACMG advises evaluating all breast cancer patients to determine the need for genetic testing

Friday, December 13th, 2019

According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.

Richmond receives legacy award from Society for Leukocyte Biology

Thursday, December 12th, 2019

Ann Richmond, PhD, Ingram Professor of Cancer Research, is the 2019 recipient of the Society for Leukocyte Biology Legacy Award.

Rathmell named interim chair of Medicine

Thursday, December 5th, 2019

W. Kimryn Rathmell, MD, PhD, has been named as interim chair of the Department of Medicine in the Vanderbilt University School of Medicine. Her appointment is effective Jan. 1, 2020.

Balko lands Mary Kay Foundation grant for breast cancer research

Thursday, December 5th, 2019

Vanderbilt-Ingram Cancer Center’s Justin Balko, PharmD, PhD, has received a $100,000 research grant from the Mary Kay Foundation.

Winning pitch

Thursday, December 5th, 2019

John Wilson, PhD, assistant professor of Chemical and Biomolecular Engineering at Vanderbilt University, received a $50,000 research grant at the 2019 Vanderbilt-Ingram Cancer Center Ambassador Breakfast.